Developed by scientists from National Taiwan University and Linkou Chang Gung Memorial Hospital.
Targets glioblastoma, known for its aggressive nature and poor prognosis.
Utilizes a nanoplatform designed to improve treatment efficacy.
Developed by scientists from National Taiwan University and Linkou Chang Gung Memorial Hospital.
Targets glioblastoma, known for its aggressive nature and poor prognosis.
Utilizes a nanoplatform designed to improve treatment efficacy.